Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Deferred Taxes (2017 - 2025)

Haemonetics (HAE) has 10 years of Deferred Taxes data on record, last reported at -$2.1 million in Q4 2025.

  • For Q4 2025, Deferred Taxes rose 14.69% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$2.6 million, up 81.76%, while the annual FY2025 figure was -$5.2 million, 52.72% up from the prior year.
  • Deferred Taxes reached -$2.1 million in Q4 2025 per HAE's latest filing, down from -$725000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $3.4 million in Q1 2025 and bottomed at -$15.9 million in Q2 2021.
  • Average Deferred Taxes over 5 years is -$2.2 million, with a median of -$2.2 million recorded in 2024.
  • The widest YoY moves for Deferred Taxes: up 593.2% in 2021, down 619.72% in 2021.
  • A 5-year view of Deferred Taxes shows it stood at -$121000.0 in 2021, then skyrocketed by 2590.91% to $3.0 million in 2022, then plummeted by 207.66% to -$3.2 million in 2023, then increased by 25.52% to -$2.4 million in 2024, then increased by 14.69% to -$2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were -$2.1 million in Q4 2025, -$725000.0 in Q3 2025, and -$3.2 million in Q2 2025.